TARGET: a survey of real‐world management of chronic myeloid leukaemia across 33 countries

Author:

Turkina Anna1,Wang Jianxiang2ORCID,Mathews Vikram3ORCID,Saydam Guray4,Jung Chul Won5,Al Hashmi Hani Hassan6,Yassin Mohamed7,Le Clanche Solenn8ORCID,Miljkovic Darko9,Slader Cassandra9,Hughes Timothy P.10ORCID

Affiliation:

1. National Research Center for Hematology Moscow Russia

2. Institute of Hematology and Blood Disease Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Tianjin China

3. Department of Haematology Christian Medical College Vellore India

4. Department of Hematology Ege University Hospital Bornova Izmir Turkey

5. Samsung Medical Center Seoul Korea

6. Adult Hematology & Hematopoietic Stem Cell Transplant Department Oncology Center King Fahad Specialist Hospital Dammam KSA Saudi Arabia

7. National Center for Cancer Care and Research Doha Qatar

8. KPL Paris France

9. Novartis Hematology Emerging Growth Markets Novartis Pharma AG Basel Switzerland

10. South Australian Health and Medical Research Institute Adelaide SA Australia

Funder

Novartis

Publisher

Wiley

Subject

Hematology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3